ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 49 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q2 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $0 | – | 392 | -2.5% | 0.00% | – |
| Q4 2022 | $0 | – | 402 | -28.2% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 560 | -98.1% | 0.00% | – |
| Q2 2022 | $14,000 | -70.8% | 28,800 | -66.0% | 0.00% | – |
| Q1 2022 | $48,000 | -63.6% | 84,775 | -61.2% | 0.00% | – |
| Q4 2021 | $132,000 | +428.0% | 218,573 | +735.2% | 0.00% | – |
| Q3 2021 | $25,000 | -46.8% | 26,170 | -39.0% | 0.00% | – |
| Q2 2021 | $47,000 | +327.3% | 42,900 | +261.6% | 0.00% | – |
| Q1 2021 | $11,000 | – | 11,864 | +169385.7% | 0.00% | – |
| Q4 2020 | $0 | -100.0% | 7 | -100.0% | 0.00% | – |
| Q3 2020 | $13,000 | – | 16,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Capital CS Group, LLC | 75,669 | $38,000 | 0.04% |
| Founders Capital Management | 18,000 | $9,000 | 0.01% |
| Verdence Capital Advisors LLC | 58,382 | $29,000 | 0.00% |
| WOLFF WIESE MAGANA LLC | 10,740 | $5,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 93,669 | $47,000 | 0.00% |
| Affinity Capital Advisors, LLC | 13,180 | $7,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 171,928 | $86,000 | 0.00% |
| B. Riley Wealth Advisors, Inc. | 25,210 | $13,000 | 0.00% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 100,000 | $50,000 | 0.00% |
| MGO ONE SEVEN LLC | 10,615 | $5,000 | 0.00% |